1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.2.1. Research Assumptions
1.2.2. Project Methodology
1.2.3. Forecast Methodology
1.2.4. Robust Quality Control
1.2.5. Key Considerations
1.2.5.1. Demographics
1.2.5.2. Economic Factors
1.2.5.3. Government Regulations
1.2.5.4. Supply Chain
1.2.5.5. COVID Impact / Related Factors
1.2.5.6. Market Access
1.2.5.7. Healthcare Policies
1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Prefilled Syringes
3.2.1. Classification of Prefilled Syringes
3.2.2. Manufacturing of Prefilled Syringes
3.2.3. Advantages of Prefilled Syringes
3.2.3.1. Benefits to Healthcare Professionals and End Users
3.2.3.2. Benefits to Manufacturers
3.3. Fill / Finish Processing of Prefilled Syringes
3.3.1. Steps Involved in Fill / Finish Process
3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
3.3.3. Prefilled Syringe Filling Technologies
3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
3.6. Advantages of Outsourcing Fill / Finish Services
3.7. Risks Associated with Outsourcing of Fill / Finish Operations
3.8. Key Considerations While Selecting a Fill / Finish Service Provider
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Scale of Operation
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
4.2.6. Analysis by Type of Drug Molecule
4.2.7. Analysis by Syringe Barrel Material
4.2.8. Analysis by Syringe Fill Volume
4.2.9. Analysis by Additional Services Offered
4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Recent Developments and Future Outlook
5.3. AMRI
5.3.1. Company Overview
5.3.2. Recent Developments and Future Outlook
5.4. BioPharma Solutions
5.4.1. Company Overview
5.4.2. Recent Developments and Future Outlook
5.5. Emergent BioSolutions
5.5.1. Company Overview
5.5.2. Recent Developments and Future Outlook
5.6. Patheon (a Thermo Fisher Scientific Company)
5.6.1. Company Overview
5.6.2. Recent Developments and Future Outlook
6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
6.1. Chapter Overview
6.2. Consort Medical
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. EVER Pharma
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. GlaxoSmithKline
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. IDT Biologika
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. Rentschler Biopharma
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Siegfried
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Vetter Pharma
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Biocon
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. Intas Pharmaceuticals
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. Kemwell Biopharma
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Square Pharmaceuticals
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. List of Expansions
8.2.1. Analysis by Year of Expansion
8.2.2. Analysis by Type of Expansion
8.2.3. Analysis by Expanded Scale of Operation
8.2.4. Analysis by Location of Expansion Project
8.2.5. Analysis by Type of Drug Molecule Involved
8.2.6. Analysis by Additional Services Offered (Expansion Specific)
8.3. Partnership Models
8.4. List of Partnerships and Collaborations
8.4.1. Analysis by Year of Partnership
8.4.2. Analysis by Type of Partnership
8.4.3. Analysis by Scale of Operation (Deal Specific)
8.4.4. Analysis by Additional Services Offered (Deal Specific)
9. CAPACITY ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Methodology
9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1. Analysis by Company Size
9.3.2. Analysis by Scale of Operation
9.3.3. Analysis by Location of Headquarters
9.3.4. Analysis by Location of Fill / Finish Facilities
9.3.5. Analysis by Type of Drug Molecule
9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
9.4.1. Analysis by Company Size (Manufacturer)
9.4.2. Analysis by Scale of Operation
9.4.3. Analysis by Location of Headquarters
9.4.4. Analysis by Location of Fill / Finish Facilities
9.4.5. Analysis by Type of Drug Molecule
10. DEMAND ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Methodology
10.3. Global Demand for Prefilled Syringes Fill / Finish Services
10.3.1. Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2. Global Demand for Clinical Prefilled Syringes Fill / Finish Services
10.4. Demand and Supply Analysis
10.4.1. Demand and Supply Analysis (Scenario 1)
10.4.2. Demand and Supply Analysis (Scenario 2)
10.4.3. Demand and Supply Analysis (Scenario 3)
11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY
11.1. Chapter Overview
11.2. Assumptions and Key Parameters
11.3. Demand and Supply Assessment in North America
11.3.1. Key Geographies
11.3.1.1. US
11.4. Demand and Supply Assessment in Europe
11.4.1. Key Geographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5. Demand and Supply Assessment in Asia-Pacific Region
11.5.1. Key Geographies
11.5.1.1. India
11.5.1.2. Japan
12. LIKELY PARTNER ANALYSIS
12.1. Chapter Overview
12.2. Methodology and Key Parameters
12.3. Likely Partner Analysis
12.3.1. Opportunities in North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2. Opportunities in Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3. Opportunities in Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
13. MARKET SIZING AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Prefilled Syringe Fill / Finish Services Market, Till 2035
13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, Till 2035
13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, Till 2035
13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, Till 2035
13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, Till 2035
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Growing Injectable Drugs Pipeline
14.3. Increase in Popularity of Prefilled Syringes
14.4. Rise in Preference for Outsourcing Fill / Finish Activities
14.5. Advances in Aseptic Fill / Finish Technologies
14.6. Growing Opportunities in the Asia-Pacific Region
15. CASE STUDY: PREFILLED SYRINGE MANUFACTURERS
15.1. Chapter Overview
15.2. Prefilled Syringes: List of Available / Under Development Devices
15.2.1. Analysis by Syringe Barrel Material
15.2.2. Analysis by Number of Barrel Chambers
15.2.3. Analysis by Type of Needle System
15.2.4. Analysis by Barrel Volume
15.3. Prefilled Syringes: List of Manufacturers
15.3.1. Analysis by Year of Establishment
15.3.2. Analysis by Location of Headquarters
16. CONCLUDING REMARKS
16.1. Chapter Overview
16.2. Key Takeaways
17. INTERVIEW TRANSCRIPTS
17.1. Chapter Overview
17.2. Company A
17.2.1. Company Snapshot
17.2.2. Interview Transcript: President and Cofounder
17.3. Company B
17.3.1. Company Snapshot
17.3.2. Interview Transcript: Chief Technical Officer
17.4. Company C
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Chief Commercial Officer
17.5. Company D
17.5.1. Company Snapshot
17.5.2. Interview Transcript: Associate Director, Head of Process Sciences Formulation and Fill / Finish
17.6. Company E
17.6.1. Company Snapshot
17.6.2. Interview Transcript: Research Director and Head of Formulation Development
17.7. Company F
17.7.1. Company Snapshot
17.7.2. Interview Transcript: Design Director
LIST OF FIGURES
Figure 3.1 Prefilled Syringe Manufacturing: Common Processes
Figure 3.2 Prefilled Syringes: Fill / Finish Process
Figure 3.3 Risks and Challenges of Outsourcing Fill / Finish Operations
Figure 3.4 Key Considerations while Selecting a Fill / Finish Service Provider
Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Prefilled Syringe Fill / Finish Facilities
Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Type of Drug Molecule
Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
Figure 4.10 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
Figure 4.11 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation and Location of Fill / Finish Facilities
Figure 4.12 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
Figure 8.1 Expansions: Distribution by Year of Expansion, Since 2015
Figure 8.2 Expansions: Distribution by Type of Expansion
Figure 8.3 Expansions: Distribution by Expanded Scale of Operation
Figure 8.4 Expansions: Distribution by Location of Expansion Project
Figure 8.5 Expansions: Distribution by Type of Drug Molecule Involved
Figure 8.6 Expansions: Distribution by Additional Services Offered (Expansion Specific)
Figure 8.7 Partnerships and Collaborations: Cumulative Trend by Year, Since 2015
Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.9 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
Figure 8.10 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Company Size (Sample Data Set)
Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Units)
Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Liters)
Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
Figure 10.2 Global, Demand for Commercialized Prefilled Syringe Fill / Finish Services
Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of North America
Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Europe
Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Asia-Pacific
Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Latin America
Figure 10.7 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Middle East and Africa
Figure 10.8 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
Figure 10.9 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
Figure 10.10 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
Figure 10.11 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
Figure 10.12 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Specialty Syringes
Figure 10.13 Global, Demand for Clinical Prefilled Syringe Fill / Finish Services
Figure 10.14 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 1)
Figure 10.15 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 2)
Figure 10.16 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 3)
Figure 11.1 Demand and Supply Assessment: North America
Figure 11.2 Demand and Supply Assessment: US
Figure 11.3 Demand and Supply Assessment: Europe
Figure 11.4 Demand and Supply Assessment: France
Figure 11.5 Demand and Supply Assessment: Germany
Figure 11.6 Demand and Supply Assessment: Italy
Figure 11.7 Demand and Supply Assessment: Asia-Pacific Region
Figure 11.8 Demand and Supply Assessment: India
Figure 11.9 Demand and Supply Assessment: Japan
Figure 12.1 Likely Partner Analysis: Distribution by Company Size and Location of Headquarters
Figure 13.1 Overall Prefilled Syringe Fill / Finish Services Market, Till 2035 (USD Billion)
Figure 13.2 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation (USD Million)
Figure 13.3 Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location (USD Million)
Figure 13.4 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, North America (USD Million)
Figure 13.5 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Europe (USD Million)
Figure 13.6 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Asia-Pacific (USD Million)
Figure 13.7 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Latin America (USD Million)
Figure 13.8 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Middle East and Africa (USD Million)
Figure 13.9 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule (USD Million)
Figure 13.10 Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area (USD Million)
Figure 13.11 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material (USD Million)
Figure 13.12 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers (USD Million)
Figure 14.1 Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
Figure 14.2 Pipeline Distribution by Route of Administration
Figure 14.3 FDA Approved Biologics and Biosimilars, Since 2014
Figure 14.4 Approved Prefilled Syringe Combination Products: Cumulative Distribution by Approval Year
Figure 14.5 Clinical Stage Prefilled Syringes Combination Products: Distribution by Phase of Development
Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
Figure 15.5 Prefilled Syringe Developers: Distribution by Year of Establishment
Figure 15.6 Prefilled Syringe Developers: Distribution by Location of Headquarters
LIST OF TABLES
Table 3.1 Classification of Prefilled Syringes
Table 4.1 Prefilled Syringe Fill / Finish Service Providers: List of Companies
Table 4.2 Prefilled Syringe Fill / Finish Service Providers: Information on Location of Fill / Finish Facilities
Table 4.3 Prefilled Syringe Fill / Finish Service Providers: Information on Type of Drug Molecule
Table 4.4 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Barrel Material
Table 4.5 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Fill Volume Range
Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Additional Services Offered
Table 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
Table 4.8 Prefilled Syringe Fill / Finish Service Providers: Information on Fill / Finish Capability
Table 5.1 Prefilled Syringes Fill / Finish Service Providers in North America: List of Profiled Companies
Table 5.2 Ajinomoto Bio-Pharma Services: Company Snapshot
Table 5.3 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
Table 5.4 AMRI: Company Snapshot
Table 5.5 AMRI: Recent Developments and Future Outlook
Table 5.6 BioPharma Solutions: Company Snapshot
Table 5.7 BioPharma Solutions: Recent Developments and Future Outlook
Table 5.8 Emergent BioSolutions: Company Snapshot
Table 5.9 Emergent BioSolutions: Recent Developments and Future Outlook
Table 5.10 Patheon: Company Snapshot
Table 5.11 Patheon: Recent Developments and Future Outlook
Table 6.1 Prefilled Syringe Fill / Finish Service Providers in Europe: List of Profiled Companies
Table 6.2 Consort Medical: Company Snapshot
Table 6.3 Consort Medical: Recent Developments and Future Outlook
Table 6.4 EVER Pharma: Company Snapshot
Table 6.5 EVER Pharma: Recent Developments and Future Outlook
Table 6.6 GlaxoSmithKline: Company Snapshot
Table 6.7 GlaxoSmithKline: Recent Developments and Future Outlook
Table 6.8 IDT Biologika: Company Snapshot
Table 6.9 IDT Biologika: Recent Developments and Future Outlook
Table 6.10 Rentschler Biopharma: Company Snapshot
Table 6.11 Rentschler Biopharma: Recent Developments and Future Outlook
Table 6.12 Siegfried: Company Snapshot
Table 6.13 Siegfried: Recent Developments and Future Outlook
Table 6.14 Vetter Pharma: Company Snapshot
Table 6.15 Vetter Pharma: Recent Developments and Future Outlook
Table 7.1 Prefilled Syringes Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
Table 7.2 Biocon: Company Snapshot
Table 7.3 Biocon: Recent Developments and Future Outlook
Table 7.4 Intas Pharmaceuticals: Company Snapshot
Table 7.5 Intas Pharmaceuticals: Recent Developments and Future Outlook
Table 7.6 Kemwell Biopharma: Company Snapshot
Table 7.7 Kemwell Biopharma: Recent Developments and Future Outlook
Table 7.8 Square Pharmaceuticals: Company Snapshot
Table 7.9 Square Pharmaceuticals: Recent Developments and Future Outlook
Table 8.1 Prefilled Syringe Fill / Finish Service Providers: Recent Expansions, Since 2015
Table 8.2 Expansions: Information on Additional Services Offered
Table 8.3 Prefilled Syringe Fill / Finish Service Providers: Partnerships and Collaborations, Since 2015
Table 8.4 Partnerships: Information on Type of Services
Table 9.1 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Average Capacity by Company Size (Sample Data Set)
Table 10.1 Global Prefilled Syringe Fill / Finish Services Annual Supply, Till 2035 (Million Units)
Table 10.2 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
Table 10.3 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
Table 10.4 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
Table 11.1 Demand and Supply Assessment: North America
Table 11.2 Demand and Supply Assessment: Europe
Table 11.3 Demand and Supply Assessment: Asia-Pacific
Table 12.1 Opportunities in North America: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.2 Opportunities in North America: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.3 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.4 Opportunities in Europe: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.5 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 12.6 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
Table 14.1 List of Pharmaceutical Robotics Manufacturers
Table 14.2 List of Companies Supplying Ready-to-Use Packaging Components
Table 14.3 Patent Expiry of Biologics, Since 2018
Table 15.1 Prefilled Syringes: List of Available / Under Development Devices
Table 15.2 Prefilled Syringes: List of Manufacturers
Table 16.1 Prefilled Syringe Fill / Finish Services Market: Key Takeaways
Table 17.1 Bio Elpida: Key Highlights
Table 17.2 Intas Pharmaceuticals: Key Highlights
Table 17.3 IDT Biologika: Key Highlights
Table 17.4 Takeda: Key Highlights
Table 17.5 Syngene: Key Highlights
Table 17.6 IDEO: Key Highlights
Table 18.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
Table 18.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
Table 18.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Table 18.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 18.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 18.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
Table 18.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
Table 18.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
Table 18.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
Table 18.10 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2015
Table 18.11 Partnerships and Collaborations: Distribution by Type of Partnership
Table 18.12 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
Table 18.13 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
Table 18.14 Most Active Players: Distribution by Number of Partnerships
Table 18.15 Expansions: Distribution by Year of Expansion, Since 2015
Table 18.16 Expansions: Distribution by Type of Expansion
Table 18.17 Expansions: Distribution by Expanded Scale of Operation
Table 18.18 Expansions: Distribution by Location of Expansion Project
Table 18.19 Expansions: Distribution by Type of Drug Molecule Involved
Table 18.20 Expansions: Distribution by Additional Services Offered (Expansion Specific)
Table 18.21 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 18.22 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
Table 18.23 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
Table 18.24 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
Table 18.25 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
Table 18.26 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
Table 18.27 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
Table 18.28 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
Table 18.29 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
Table 18.30 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
Table 18.31 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
Table 18.32 Global, Demand for Prefilled Syringe Fill / Finish Services
Table 18.33 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
Table 18.34 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
Table 18.35 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
Table 18.36 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
Table 18.37 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
Table 18.38 Demand and Supply Assessment: North America
Table 18.39 Demand and Supply Assessment: Europe
Table 18.40 Demand and Supply Assessment: Asia-Pacific and Rest of the World
Table 18.41 Likely Partner Analysis: Distribution by Geography
Table 18.42 Overall Prefilled Syringe Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
Table 18.43 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.44 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.45 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.46 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.47 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.48 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers, Conservative, Base and Optimistic Scenarios, (USD Million)
Table 18.49 Prefilled Syringes: Distribution by Syringe Barrel Material
Table 18.50 Prefilled Syringes: Distribution by Number of Barrel Chambers
Table 18.51 Prefilled Syringes: Distribution by Type of Needle System
Table 18.52 Prefilled Syringes: Distribution by Barrel Volume
Table 18.53 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
Table 18.54 Prefilled Syringe Manufacturers: Distribution by Company Size
Table 18.55 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters
